BRIEF-Loxo Oncology reports acceptance of larotrectinib oral presentations at ASCO annual meeting
April 5 Loxo Oncology Inc:
* Loxo Oncology announces acceptance of larotrectinib oral presentations at the American Society Of Clinical Oncology (asco) annual meeting Source text for Eikon: Further company coverage:
Biggest U.S. equity outflows in 5 weeks -BAML
LONDON, June 23 Investors pulled $7.7 billion from U.S. equities, the biggest outflows in five weeks, data from Bank of America Merrill Lynch (BAML) showed on Friday, reversing the previous week's bumper inflows as bears battled with the bulls.